Description
Within the past decade, we have witnessed an increased adoption of emerging technologies as well as the exponential pace of scientific discoveries within all industries. The level of digital innovation and digital transformation experienced in healthcare and life sciences has been markedly accelerated by the COVID-19 pandemic. There is a new sense of urgency to design and develop a new global health ecosystem that is more suitable for the digital era and future generations. Deploying precision medicine solutions that can redefine the way we diagnose and treat disease, as well as shift the focus towards a customized human-centered approach, such as those offered by personalized medicine, can be a viable sustainable model.
Digital Identity in the New Era of Personalized Medicine highlights the latest trends in precision medicine and the important role digital identity plays in upholding ethical values, safeguarding human rights, and practicing responsible personalized medicine. It provides an overview of the current healthcare legal and regulatory landscapes as well as some of the major challenges and opportunities we face in this digital, virtual, and precision medicine-powered era. Covering topics such as data-centric compliance, global health, and identity management, this book is an essential resource for doctors, healthcare administration, academicians, clinicians, health and bio-tech executives, researchers, medical professionals, medical engineers, medical students, and government officials looking for a resource that addresses challenges in healthcare including trust, privacy, data integrity, and ownership.
Author's/Editor's Biography
Ingrid Vasiliu-Feltes (Ed.)
Ingrid Vasiliu-Feltes is an Expert Advisor to the EU Blockchain Observatory Forum, serves as a Board Member of UN Legal and Economic Empowerment Network. Founder and CEO of The Science, Entrepreneurship and Investments Institute. Country Director for WBAF USA, Senator of WBAF, Faculty Member of the WBAF Business School-Division of Entrepreneurship, and teaching the Executive MBA Business Technology Course at the UM Business School. Chief Innovation Officer and past Chief Ethics Officer for GBA Global, Senator and as the Chief Quality and Safety Officer at MEDNAX and provides leadership to the MEDNAX Center for Research, Education, Quality and Safety. During her academic tenure she taught 50 + courses and served Chief of Compliance and Director of Research. Member of numerous prestigious professional organizations. She holds several certifications, such as Bioethics from Harvard, AI and Business Strategy from MIT Sloan, Blockchain Technology and Business Innovation from MIT Sloan, Finance from Harvard Business School, Negotiation from Harvard Law School, Innovation and Entrepreneurship from Stanford Graduate School of Business, Fellow of the American College of Healthcare Executives, Master Black Belt in Lean and Six Sigma Management.